EX-23.6 12 tm2116866d2_ex23-6.htm EXHIBIT 23.6

 

Exhibit 23.6

 

 

AstraZeneca PLC
Legal & Secretary’s Department
1 Francis Crick Avenue
Cambridge Biomedical Campus
Cambridge CB2 OAA
England

 

AstraZeneca Finance LLC

1209 Orange Street

Wilmington, Delaware 19801

United States

 

For the attention of Adrian Kemp and Mariam Koohdary
By email & by post

 

24 May 2021

 

Dear Ladies and Gentlemen

 

BUREAU VERITAS STATEMENT OF ASSURANCE FOR ANNUAL REPORT AND FORM 20-F INFORMATION 2020

 

In connection with the filing of the accompanying Registration Statement on Form F-3 (the “Form F-3”) of AstraZeneca PLC (“AstraZeneca”) and AstraZeneca Finance LLC (“AstraZeneca Finance”), Bureau Veritas hereby authorizes AstraZeneca and AstraZeneca Finance LLC to refer to Bureau Veritas's external assurance on corporate responsibility related information as stated on page 275 and as identified on the pages included in Exhibit 15.4 to AstraZeneca's Annual Report and Form 20-F Information for the fiscal year ended December 31, 2020 (the “Annual Report”), which Annual Report is incorporated by reference in the accompanying Form F-3 of AstraZeneca and AstraZeneca Finance LLC, subject to the same acknowledgements and agreements as set forth in our letter included in Exhibit 15.4 to the Annual Report. Please indicate your agreement to the foregoing by signing in the space indicated below. Our authorization will not become effective until accepted and agreed by AstraZeneca and AstraZeneca Finance.

 

Very truly yours,

/s/ Julie-Anna Smith 

Name: Julie-Anna Smith

Title: Head of Technical Centre


For and on behalf of Bureau Veritas UK Ltd

 

ACCEPTED AND AGREED
This 24th day of May 2021

 

 

AstraZeneca PLC

 

/s/ Adrian Kemp 

Name: Adrian Kemp
Title: Company Secretary

 

ACCEPTED AND AGREED
This 24th day of May 2021

 

 

 

 

AstraZeneca Finance LLC

 

/s/ Mariam Koohdary 

Name: Mariam Koohdary
Title: President & Secretary